475
Views
10
CrossRef citations to date
0
Altmetric
Research Article

Metabolomics approach to biomarkers of dry eye disease using 1H-NMR in rats

, , , , , , & show all

References

  • Ananieva, E. A., J. D. Powell, and S. M. Hutson. 2016. Leucine metabolism in T cell activation: MTOR signaling and beyond. Adv. Nutr. 7:798S–805S. doi:10.3945/an.115.011221.
  • Barabino, S., and M. R. Dana. 2004. Animal models of dry eye: A critical assessment of opportunities and limitations. Invest. Ophthalmol. Vis. Sci. 45:1641–46. doi:10.1167/iovs.03-1055.
  • Bartneck, M., V. Fech, J. Ehling, O. Govaere, K. T. Warzecha, K. Hittatiya, M. Vucur, J. Gautheron, T. Luedde, C. Trautwein, et al. 2016. Histidine-rich glycoprotein promotes macrophage activation and inflammation in chronic liver disease. Hepatology 63:1310–24. doi:10.1002/hep.28418.
  • Baudouin, C. 2001. The pathology of dry eye. Surv. Ophthalmol. 45 (Suppl 2):S211–S220. doi:10.1016/S0039-6257(00)00200-9.
  • Boldyrev, A. A., G. Aldini, and W. Derave. 2013. Physiology and pathophysiology of carnosine. Physiol. Rev. 93:1803–45. doi:10.1152/physrev.00039.2012.
  • Bonvallot, N., M. Tremblay-Franco, C. Chevrier, C. Canlet, L. Debrauwer, J. P. Cravedi, and S. Cordier. 2014. Potential input from metabolomics for exploring and understanding the links between environment and health. J. Toxicol. Environ. Health. B. 17:21–44. doi:10.1080/10937404.2013.860318.
  • Brignole, F., P. J. Pisella, M. Goldschild, M. De Saint Jean, A. Goguel, and C. Baudouin. 2000. Flow cytometric analysis of inflammatory markers in conjunctival epithelial cells of patients with dry eyes. Invest. Ophthalmol. Vis. Sci. 41:1356–63.
  • Chen, L., L. Zhou, E. C. Chan, J. Neo, and R. W. Beuerman. 2011. Characterization of the human tear metabolome by LC-MS/MS. J. Proteome. Res. 10:4876–82. doi:10.1021/pr2004874.
  • Chen, X., J. Rao, Z. Zheng, Y. Yu, S. Lou, L. Liu, Q. He, L. Wu, and X. Sun. 2019. Integrated tear proteome and metabolome reveal panels of inflammatory-related molecules via key regulatory pathways in dry eye syndrome. J. Proteome. Res. 18:2321–30. doi:10.1021/acs.jproteome.9b00149.
  • Corrales, R. M., A. Villarreal, W. Farley, M. E. Stern, D. Q. Li, and S. C. Pflugfelder. 2007. Strain-related cytokine profiles on the murine ocular surface in response to desiccating stress. Cornea 26:579–84. doi:10.1097/ICO.0b013e318033a729.
  • De Paiva, C. S., A. L. Villarreal, R. M. Corrales, H. T. Rahman, V. Y. Chang, W. J. Farley, M. E. Stern, J. Y. Niederkorn, D. Q. Li, and S. C. Pflugfelder. 2007. Dry eye-induced conjunctival epithelial squamous metaplasia is modulated by interferon-gamma. Invest. Ophthalmol. Vis. Sci. 48:2553–60. doi:10.1167/iovs.07-0069.
  • ECHA (European Chemicals Agency). 2020. Hyoscine toxicological information. https://echa.europa.eu/registration-dossier/-/registered-dossier/20490/7/2/1#.
  • Foulks, G. N. 2008. Pharmacological management of dry eye in the elderly patient. Drugs. Aging. 25:105–18. doi:10.2165/00002512-200825020-00003.
  • Galbis-Estrada, C., M. D. Pinazo-Duran, S. Martinez-Castillo, J. M. Morales, D. Monleon, and V. Zanon-Moreno. 2015. A metabolomic approach to dry eye disorders: The role of oral supplements with antioxidants and omega 3 fatty acids. Mol. Vis. 21:555–67.
  • Galbis-Estrada, C., S. Martinez-Castillo, J. M. Morales, B. Vivar-Llopis, D. Monleón, M. Díaz-Llopis, and M. D. Pinazo-Durán. 2014. Differential effects of dry eye disorders on metabolomic profile by 1H nuclear magnetic resonance spectroscopy. Biomed. Res. Int. 2014:542549. doi:10.1155/2014/542549.
  • Gayton, J. L. 2009. Etiology, prevalence, and treatment of dry eye disease. Clin. Ophthalmol. 3:405–12. doi:10.2147/OPTH.S5555.
  • Gebregiworgis, T., C. Massilamany, A. Gangaplara, S. Thulasingam, V. Kolli, M. T. Werth, E. D. Dodds, D. Steffen, J. Reddy, and R. Powers. 2013. Potential of urinary metabolites for diagnosing multiple sclerosis. ACS Chem. Biol. 8:684–90. doi:10.1021/cb300673e.
  • Gebregiworgis, T., H. H. Nielsen, C. Massilamany, A. Gangaplara, J. Reddy, Z. Illes, and R. Powers. 2016. A urinary metabolic signature for multiple sclerosis and neuromyelitis optica. J. Proteome Res. 15:659–66. doi:10.1021/acs.jproteome.5b01111.
  • Hagan, S., E. Martin, and A. Enríquez-de-Salamanca. 2016. Tear fluid biomarkers in ocular and systemic disease: Potential use for predictive, preventive and personalised medicine. Epma J. 7:15. doi:10.1186/s13167-016-0065-3.
  • HIRA (Health insurance review and assessment service) 2020. Health and medical big data opening system. Available from: http://opendata.hira.or.kr/op/opc/olapMfrnIntrsIlnsInfo.do
  • Holeček, M. 2020. Histidine in health and disease: Metabolism, physiological importance, and use as a supplement. Nutrients 12:848. doi:10.3390/nu12030848.
  • Honda, M., K. Takehana, A. Sakai, Y. Tagata, T. Shirasaki, S. Nishitani, T. Muramatsu, T. Yamashita, Y. Nakamoto, E. Mizukoshi, et al., Hokuriku Liver Study Group. 2011. Malnutrition impairs interferon signaling through mTOR and FoxO pathways in patients with chronic hepatitis C. Gastroenterology 141: 128–40. doi: 10.1053/j.gastro.2011.03.051.
  • Infantino, V., V. Iacobazzi, A. Menga, M. L. Avantaggiati, and F. Palmieri. 2014. A key role of the mitochondrial citrate carrier (SLC25A1) in TNFα- and IFNγ-triggered inflammation. Biochim. Biophys. Acta 1839:1217–25. doi:10.1016/j.bbagrm.2014.07.013.
  • Ingle, R. A. 2011. Histidine biosynthesis. Arabidopsis. Book 9:e0141. doi:10.1199/tab.0141.
  • Inomata, T., M. Iwagami, Y. Hiratsuka, K. Fujimoto, Y. Okumura, T. Shiang, and A. Murakami. 2018. Maximum blink interval is associated with tear film breakup time: A new simple, screening test for dry eye disease. Sci. Rep. 8:13443. doi:10.1038/s41598-018-31814-7.
  • Jackson, D. C., W. Zeng, C. Y. Wong, E. J. Mifsud, N. A. Williamson, C. S. Ang, A. J. Vingrys, and L. E. Downie. 2016. Tear interferon-gamma as a biomarker for evaporative dry eye disease. Invest. Ophthalmol. Vis. Sci. 57:4824–30. doi:10.1167/iovs.16-19757.
  • Jang, H. J., J. D. Lee, H. S. Jeon, A. R. Kim, S. Kim, H. S. Lee, and K. B. Kim. 2018. Metabolic profiling of eccentric exercise-induced muscle damage in human urine. Toxicol. Res. 34:199–210. doi:10.5487/TR.2018.34.3.199.
  • Jiang, Y., C. Yang, Y. Zheng, Y. Liu, and Y. Chen. 2020. A set of global metabolomic biomarker candidates to predict the risk of dry eye disease. Front. Cell. Dev. Biol. 8:344. doi:10.3389/fcell.2020.00344.
  • Jung, J. Y., H. S. Lee, D. G. Kang, N. S. Kim, M. H. Cha, O. S. Bang, D. H. Ryu, and G. S. Hwang. 2011. 1H-NMR-based metabolomics study of cerebral infarction. Stroke 42:1282–88. doi:10.1161/STROKEAHA.110.598789.
  • Kakazu, E., Y. Ueno, Y. Kondo, K. Fukushima, M. Shiina, J. Inoue, K. Tamai, M. Ninomiya, and T. Shimosegawa. 2009. Branched chain amino acids enhance the maturation and function of myeloid dendritic cells ex vivo in patients with advanced cirrhosis. Hepatology 50:1936–45. doi:10.1002/hep.23248.
  • Kessler, A. T., and A. Raja. 2020. Biochemistry, Histidine. In StatPearls [Internet]. Treasure Island, FL: StatPearls Publishing.
  • Kim, J. W., S. H. Ryu, S. Kim, H. W. Lee, M. S. Lim, S. J. Seong, S. Kim, Y. R. Yoon, and K. B. Kim. 2013. Pattern recognition analysis for hepatotoxicity induced by acetaminophen using plasma and urinary 1H NMR-based metabolomics in humans. Anal. Chem. 85:11326–34. doi:10.1021/ac402390q.
  • Kim, K. B., and B. M. Lee. 2009. Metabolomics, a new promising technology for toxicological research. Toxicol. Res. 25:59–69. doi:10.5487/TR.2009.25.2.059.
  • Kim, K. B., J. Y. Yang, S. J. Kwack, K. L. Park, H. S. Kim, D. H. Ryu, Y. J. Kim, G. S. Hwang, and B. M. Lee. 2010. Toxicometabolomics of urinary biomarkers for human gastric cancer in a mouse model. J. Toxicol. Environ. Health A. 73:1420–30. doi:10.1080/15287394.2010.511545.
  • Lam, S. M., L. Tong, X. Duan, U. R. Acharya, J. H. Tan, A. Petznick, M. R. Wenk, and G. Shui. 2014. Longitudinal changes in tear fluid lipidome brought about by eyelid-warming treatment in a cohort of meibomian gland dysfunction. J. Lipid. Res. 55:1959–69. doi:10.1194/jlr.P051185.
  • Lauwen, S., E. K. de Jong, D. J. Lefeber, and A. L. den Hollander. 2017. Omics biomarkers in ophthalmology. Invest. Ophthalmol. Vis. Sci 58:BIO88–BIO98. doi:10.1167/iovs.17-21809.
  • Lee, J. D., H. Y. Kim, K. Kang, H. G. Jeong, M. K. Song, I. H. Tae, S. H. Lee, H. R. Kim, K. Lee, S. Chae, et al. 2020. Integration of transcriptomics, proteomics and metabolomics identifies biomarkers for pulmonary injury by polyhexamethylene guanidine phosphate (PHMG-p), a humidifier disinfectant, in rats. Arch. Toxicol. 94:887–909. doi:10.1007/s00204-020-02657-x.
  • Li, D. Q., L. Luo, Z. Chen, H. S. Kim, X. J. Song, and S. C. Pflugfelder. 2006. JNK and ERK MAP kinases mediate induction of IL-1beta, TNF-alpha and IL-8 following hyperosmolar stress in human limbal epithelial cells. Exp. Eye. Res. 82:588–96. doi:10.1016/j.exer.2005.08.019.
  • Li, D. Q., Z. Chen, X. J. Song, L. Luo, and S. C. Pflugfelder. 2004. Stimulation of matrix metalloproteinases by hyperosmolarity via a JNK pathway in human corneal epithelial cells. Invest. Ophthalmol. Vis. Sci. 45:4302–11. doi:10.1167/iovs.04-0299.
  • Li, K., C. Zhang, Z. Yang, Y. Wang, and H. Si. 2017. Evaluation of a novel dry eye model induced by oral administration of finasteride. Mol. Med. Rep. 16:8763–70. doi:10.3892/mmr.2017.7754.
  • Li, Z., J. M. Woo, S. W. Chung, M. Y. Kwon, J. S. Choi, H. J. Oh, and K. C. Yoon. 2013. Therapeutic effect of topical adiponectin in a mouse model of desiccating stress-induced dry eye. Invest. Ophthalmol. Vis. Sci. 54:155–62. doi:10.1167/iovs.12-10648.
  • Li, Z., W. Choi, H. J. Oh, and K. C. Yoon. 2012. Effectiveness of topical infliximab in a mouse model of experimental dry eye. Cornea (Suppl 1):S25–S31. doi:10.1097/ICO.0b013e31826a80ea.
  • Luo, L., D. Q. Li, A. Doshi, W. Farley, R. M. Corrales, and S. C. Pflugfelder. 2004. Experimental dry eye stimulates production of inflammatory cytokines and MMP-9 and activates MAPK signaling pathways on the ocular surface. Invest. Ophthalmol. Vis. Sci. 45:4293–301. doi:10.1167/iovs.03-1145.
  • McGettrick, A. F., and L. A. O’Neill. 2013. How metabolism generates signals during innate immunity and inflammation. J. Biol. Chem. 288:22893–98. doi:10.1074/jbc.R113.486464.
  • Mills, E., and L. A. J. O’Neill. 2014. Succinate: A metabolic signal in inflammation. Trends. Cell. Biol. 24:313–20. doi:10.1016/j.tcb.2013.11.008.
  • Mills, E. L., B. Kelly, A. Logan, A. S. H. Costa, M. Varma, C. E. Bryant, P. Tourlomousis, J. H. M. Däbritz, E. Gottlieb, I. Latorre, et al. 2016. Succinate dehydrogenase supports metabolic repurposing of mitochondria to drive inflammatory macrophages. Cell 167:457–470.e13. doi:10.1016/j.cell.2016.08.064.
  • Nakatsukasa, M., C. Sotozono, K. Shimbo, N. Ono, H. Miyano, A. Okano, J. Hamuro, and S. Kinoshita. 2011. Amino acid profiles in human tear fluids analyzed by high-performance liquid chromatography and electrospray ionization tandem mass spectrometry. Am. J. Ophthalmol. 151:799–808.e1. doi:10.1016/j.ajo.2010.11.003.
  • Narayanan, S., W. L. Miller, and A. M. McDermott. 2006. Conjunctival cytokine expression in symptomatic moderate dry eye subjects. Invest. Ophthalmol. Vis. Sci. 47:2445–50. doi:10.1167/iovs.05-1364.
  • Nazifova-Tasinova, N., M. Radeva, B. Galunska, and C. Grupcheva. 2020. Metabolomic analysis in ophthalmology. Biomed. Pap. Med. Fac. Univ. Palacky. Olomouc. Czech. Repub. 164:236–46. doi:10.5507/bp.2020.028.
  • Niederkorn, J. Y., M. E. Stern, S. C. Pflugfelder, C. S. De Paiva, R. M. Corrales, J. Gao, and K. Siemasko. 2006. Desiccating stress induces T cell-mediated Sjögren’s syndrome-like lacrimal keratoconjunctivitis. J. Immunol. 176:3950–57. doi:10.4049/jimmunol.176.7.3950.
  • Pieragostino, D., L. Agnifili, I. Cicalini, R. Calienno, M. Zucchelli, L. Mastropasqua, P. Sacchetta, P. Del Boccio, and C. Rossi. 2017. Tear film steroid profiling in dry eye disease by liquid chromatography tandem mass spectrometry. Int. J. Mol. Sci. 18:1349. doi:10.3390/ijms18071349.
  • Pinto-Fraga, J., A. Enríquez-de-Salamanca, M. Calonge, M. J. González-García, A. López-Miguel, A. López-de la Rosa, C. García-Vázquez, V. Calder, M. E. Stern, and I. Fernández. 2018. Severity, therapeutic, and activity tear biomarkers in dry eye disease: An analysis from a phase III clinical trial. Ocul. Surf. 16:368–76. doi:10.1016/j.jtos.2018.05.001.
  • Pisitkun, T., R. Johnstone, and M. A. Knepper. 2006. Discovery of urinary biomarkers. Mol. Cell. Proteomics. 5:1760–71. doi:10.1074/mcp.R600004-MCP200.
  • Poon, I. K., K. K. Patel, D. S. Davis, C. R. Parish, and M. D. Hulett. 2011. Histidine-rich glycoprotein: The Swiss Army knife of mammalian plasma. Blood 117:2093–101. doi:10.1182/blood-2010-09-303842.
  • Renner, U. D., R. Oertel, and W. Kirch. 2005. Pharmacokinetics and pharmacodynamics in clinical use of scopolamine. Ther. Drug. Monit. 27:655–65. doi:10.1097/01.ftd.0000168293.48226.57.
  • Research Subcommittee of the International Dry Eye WorkShop. 2007. Research in dry eye: Report of the Research Subcommittee of the International Dry Eye WorkShop. Ocul. Surf 5: 179–93. doi:10.1016/S1542-0124(12)70086-1.
  • Rinschen, M. M., J. Ivanisevic, M. Giera, and G. Siuzdak. 2019. Identification of bioactive metabolites using activity metabolomics. Nat. Rev. Mol. Cell. Biol. 20:353–67. doi:10.1038/s41580-019-0108-4.
  • Rivas, L., M. A. Oroza, A. Perez-Esteban, and J. Murube-del-Castillo. 1992. Morphological changes in ocular surface in dry eyes and other disorders by impression cytology. Graefes. Arch. Clin. Exp. Ophthalmol. 230:329–34. doi:10.1007/BF00165940.
  • Rolny, C., M. Mazzone, S. Tugues, D. Laoui, I. Johansson, C. Coulon, M. L. Squadrito, I. Segura, X. Li, E. Knevels, et al. 2011. HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PlGF. Cancer. Cell. 19:31–44. doi:10.1016/j.ccr.2010.11.009.
  • Rosique, C., D. Lebsir, P. Lestaevel, S. Benatia, P. Guigon, F. Caire-Maurisier, M. Benderitter, D. Bennouna, M. Souidi, and J. C. Martin. 2019. Assessment of the effects of repeated doses of potassium iodide intake during pregnancy on male and female rat offspring using metabolomics and lipidomics. J. Toxicol. Environ. Health A. 82:603–15. doi:10.1080/15287394.2019.1625474.
  • Ryu, S. H., J. D. Lee, J. W. Kim, S. Kim, and K. B. Kim. 2019. 1H NMR toxicometabolomics following cisplatin-induced nephrotoxicity in male rats. J. Toxicol. Sci. 44:57–71. doi:10.2131/jts.44.57.
  • Ryu, S. H., J. W. Kim, D. Yoon, S. Kim, and K. B. Kim. 2018. Serum and urine toxicometabolomics following gentamicin-induced nephrotoxicity in male Sprague-Dawley rats. J. Toxicol. Environ. Health A. 81:408–20. doi:10.1080/15287394.2018.1451180.
  • Schicho, R., R. Shaykhutdinov, J. Ngo, A. Nazyrova, C. Schneider, R. Panaccione, G. G. Kaplan, H. J. Vogel, and M. Storr. 2012. Quantitative metabolomic profiling of serum, plasma, and urine by (1)H NMR spectroscopy discriminates between patients with inflammatory bowel disease and healthy individuals. J. Proteome Res. 11:3344–57. doi:10.1021/pr300139q.
  • Spittler, A., C. M. Reer, R. Oehler, A. Gornikiewicz, T. Gruenberger, N. Manhart, T. Brodowicz, M. Mittlboeck, G. Boltz-Nitulescu, and E. Roth. 1999. Immunomodulatory effects of glycine on LPS-treated monocytes: Reduced TNF-alpha production and accelerated IL-10 expression. Faseb J. 13:563–71. doi:10.1096/fasebj.13.3.563.
  • Stern, M. E., J. Gao, K. F. Siemasko, R. W. Beuerman, and S. C. Pflugfelder. 2004. The role of the lacrimal functional unit in the pathophysiology of dry eye. Exp. Eye. Res. 78:409–16. doi:10.1016/j.exer.2003.09.003.
  • Stern, M. E., K. F. Siemasko, J. Gao, M. Calonge, J. Y. Niederkorn, and S. C. Pflugfelder. 2005. Evaluation of ocular surface inflammation in the presence of dry eye and allergic conjunctival disease. Ocul. Surf. 3:S161–164. doi:10.1016/S1542-0124(12)70246-X.
  • Stern, M. E., and S. C. Pflugfelder. 2004. Inflammation in dry eye. Ocul. Surf. 2:124–30. doi:10.1016/S1542-0124(12)70148-9.
  • Sullivan, B. D., L. A. Crews, E. M. Messmer, G. N. Foulks, K. K. Nichols, P. Baenninger, G. Geerling, F. Figueiredo, and M. A. Lemp. 2014. Correlations between commonly used objective signs and symptoms for the diagnosis of dry eye disease: Clinical implications. Acta. Ophthalmol. 92:161–66. doi:10.1111/aos.12012.
  • Tran, Q., H. Lee, J. Park, S. H. Kim, and J. Park. 2016. Targeting cancer metabolism - revisiting the Warburg effects. Toxicol. Res. 32:177–93. doi:10.5487/TR.2016.32.3.177.
  • Viau, S., B. Pasquis, M. A. Maire, C. Fourgeux, S. Grégoire, N. Acar, L. Bretillon, C. P. Creuzot-Garcher, and C. Joffre. 2011. No consequences of dietary n-3 polyunsaturated fatty acid deficiency on the severity of scopolamine-induced dry eye. Graefes. Arch. Clin. Exp. Ophthalmol. 249:547–57. doi:10.1007/s00417-010-1576-6.
  • Viau, S., M. A. Maire, B. Pasquis, S. Grégoire, C. Fourgeux, N. Acar, L. Bretillon, C. P. Creuzot-Garcher, and C. Joffre. 2008. Time course of ocular surface and lacrimal gland changes in a new scopolamine-induced dry eye model. Graefes. Arch. Clin. Exp. Opthalmol. 246:857–67. doi:10.1007/s00417-008-0784-9.
  • Viau, S., M. A. Maire, B. Pasquis, S. Grégoire, N. Acar, A. M. Bron, L. Bretillon, C. P. Creuzot-Garcher, and C. Joffre. 2009. Efficacy of a 2-month dietary supplementation with polyunsaturated fatty acids in dry eye induced by scopolamine in a rat model. Graefes. Arch. Clin. Exp. Opthalmol. 247:1039–50. doi:10.1007/s00417-009-1080-z.
  • Wada, S., T. Yoshimitsu, N. Koga, H. Yamada, K. Oguri, and H. Yoshimura. 1991. Metabolism in vivo of the tropane alkaloid, scopolamine, in several mammalian species. Xenobiotica 21:1289–300. doi:10.3109/00498259109043204.
  • Wang, W., Z. Wu, Z. Dai, Y. Yang, J. Wang, and G. Wu. 2013. Glycine metabolism in animals and humans: Implications for nutrition and health. Amino. Acids. 45:463–77. doi:10.1007/s00726-013-1493-1.
  • Williams, N. C., and L. A. J. O’Neill. 2018. A role for the Krebs cycle intermediate citrate in metabolic reprogramming in innate immunity and inflammation. Front. Immunol. 9:141.eCollection. doi:10.3389/fimmu.2018.00141.
  • Wishart, D. S. 2008. Quantitative metabolomics using NMR. Trends Anal Chem. 27:228–237.
  • Xia, J., and D. S. Wishart. 2016. Using MetaboAnalyst 3.0 for comprehensive metabolomics data analysis. Curr Protoc Bioinformatics 55:14. doi:10.1002/cpbi.11.
  • Yazdani, M., K. B. P. Elgstøen, H. Rootwelt, A. Shahdadfar, Ø. A. Utheim, and T. P. Utheim. 2019. Tear metabolomics in dry eye disease: A Review. Int. J. Mol. Sci. 20:3755. doi:10.3390/ijms20153755.
  • Yoon, K. C., I. Y. Jeong, Y. G. Park, and S. Y. Yang. 2007. Interleukin-6 and tumor necrosis factor-alpha levels in tears of patients with dry eye syndrome. Cornea 26:431–37. doi:10.1097/ICO.0b013e31803dcda2.
  • Yoon, K. C., K. Y. Ahn, W. Choi, Z. Li, J. S. Choi, S. H. Lee, and S. H. Park. 2011. Tear production and ocular surface changes in experimental dry eye after elimination of desiccating stress. Invest. Ophthalmol. Vis. Sci. 52:7267–73. doi:10.1167/iovs.11-7231.
  • Young, S. P., and G. R. Wallace. 2009. Metabolomic analysis of human disease and its application to the eye. J. Ocul. Biol. Dis. Infor. 2:235–42. doi:10.1007/s12177-009-9038-2.
  • Zhao, H., Q. Li, M. Ye, and J. Yu. 2018. Tear luminex analysis in dry eye patients. Med. Sci. Monit. 24:7595–602. doi:10.12659/MSM.912010.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.